Funds

31 articles

Three ETFs That Can Cushion a Portfolio Without Market Timing

These three ETFs take different approaches to portfolio risk without requiring investors to move everything to cash. None can prevent losses or predict when a market downturn will come.

View Story

Three ETFs to Consider Before a Downturn

Healthcare stocks and bonds may cushion some recession pressure, while broad-market funds keep stock exposure in the mix. The trade-offs include company concentration and the risk that bonds lose value when rates rise.

View Story

XLP Has Lower Fees; IYK Has Higher 10-Year Returns

XLP charges 0.08% and yields 2.73%. IYK's reported 10-year return is higher, at 134%. The choice comes down to whether lower costs and income matter more than historical growth.

View Story

ARKX vs. XAR: Which Aerospace and Defense ETF Fits Your Portfolio?

ARKX returned more than XAR over the trailing year in the reported snapshot, but it charges more and showed greater volatility. Over four years, the funds finished almost even.

View Story

VOO's lower fees challenge QQQ's growth edge

Over five years, $1,000 grew to $2,108 in QQQ and $1,892 in VOO. QQQ's higher fee and heavier technology concentration add risk for investors weighing growth against diversification.

View Story

SOXX Turned a $5,000 Investment in 2001 Into $118,240

SOXX has surged during the AI boom, but it lagged the S&P 500 for its first 15 years. Its record shows the potential gains and risks of investing in one industry.

View Story

Four Infrastructure ETFs Raise Monthly Payouts for September

Infrastructure Capital raised monthly distributions for QVOL, BNDS, SCAP and ICAP. The new payments are due September 30, but QVOL's targeted annual rate is neither a yield nor a guaranteed return.

View Story

A Diesel Export Ban Could Raise Costs Across the U.S. Energy Market

Diesel reached $6.5276 a gallon on September 22, up 83% in 2026. A proposed export ban could redirect supply at home, but refinery cuts could push gasoline costs higher.

View Story

Emerging Markets ETF dividend surges as FEM lifts payout

First Trust Emerging Markets AlphaDEX Fund just raised its quarterly dividend by 50 percent to $0.2849 per share. The move pushes its annual yield to about 3.5 percent and is drawing new interest from income-focused investors.

View Story

Target Healthcare REIT posts record year and lifts dividend

Target Healthcare REIT delivered its best results since going public in 2013, raising its dividend as property values and profits climbed in a tough market.

View Story

ETF buyers face limited Anthropic exposure ahead of IPO

Investors hoping to profit from Anthropic's IPO by buying ETFs with private shares may be disappointed as actual exposure is small and key financial details remain undisclosed

View Story

Dividend Growth Stocks Offer Stability Amid Rising Market Volatility

Dividend growth stocks have historically delivered higher average returns with less volatility than the broader market since 1960. Learn how a dividend growth ETF can help reduce risk without sacrificing long-term performance.

View Story

Hargreave Hale AIM VCT sets share price for special dividend reinvestment

Investors in Hargreave Hale AIM VCT face a 31.50 pence share price for dividend reinvestment as the trust confirms payout and new share dates for 2026

View Story

Dividend ETF choices for steady income in volatile markets

Three dividend ETFs with low fees and a focus on quality aim to deliver consistent income and capital preservation for investors seeking stability over high yields

View Story

Morningstar ratings can mislead investors who ignore this key difference

A 5-star badge on your mutual fund may look impressive but it signals something very different from Morningstar's gold rating. Understanding the distinction could mean the difference between chasing past winners and building a resilient portfolio

View Story

Tesla and SpaceX losses hit ARK Innovation ETF after Cybercab event

Tesla's nearly 6 percent drop after its Cybercab launch and a federal safety audit triggered a decline in ARK Innovation ETF which has 16 percent of its assets tied to Tesla and SpaceX

View Story

SCHD closes in on VIG as dividend ETF rivalry reshapes portfolios

SCHD has surged nearly 30 percent this year while VIG lags far behind. With yields and sector bets diverging sharply, the stakes for retirement and income investors are rising fast

View Story

VanEck Semiconductor ETF: The AI Gold Rush's Top Performer

The VanEck Semiconductor ETF (SMH) has outpaced major indexes with a 32% average annualized return over the past decade, as surging AI demand drives semiconductor stocks higher and reshapes the investment landscape

View Story

The Nasdaq 100: A 20-Year Investment Success Story

A $1,000 investment in the Nasdaq 100 two decades ago would now be worth over $21,000, but that growth required withstanding multiple steep market drops and staying invested through volatility

View Story

Vanguard Brings T. Rowe Price Onboard for Three Major Equity Funds

Vanguard is shifting management of key active equity funds, adding T. Rowe Price as a new subadvisor and adjusting fund strategies. The move affects over $42 billion in assets and brings modest fee changes for investors

View Story

Vanguard's Total World ETF Offers Global Diversification for $6 a Year

For $6 per $10,000 invested, Vanguard's Total World Stock ETF gives exposure to more than 10,000 companies worldwide. Here's how its structure, holdings, and performance compare to U.S.-only funds and what investors should know about global diversification

View Story

The Safest Place to Park Your Money in a Bear Market

When markets turn volatile, the Vanguard High Dividend Yield Index Fund ETF has a track record of smaller losses than the S&P 500, but investors should weigh its long-term trade-offs before shifting their portfolios

View Story

Schwab U.S. Dividend Equity ETF vs. Vanguard High Dividend Yield ETF: Which Is Better for Income Investors?

SCHD and VYM both offer low fees and broad exposure, but SCHD's higher yield and sector mix may appeal to risk-averse investors seeking steady income while VYM targets those prioritizing dividend growth and sector diversification

View Story

How Much You Need to Invest for $1,000 Monthly in SCHD

The Schwab U.S. Dividend Equity ETF draws attention for its steady payouts, but earning $1,000 a month in dividends requires a sizable investment and comes with important trade-offs for income-focused investors

View Story

Why SEC Mutual Fund Standards Matter for Retirement Investors

Retirement plan fiduciaries face growing pressure to evaluate investment performance, but not all funds are held to the same standards. Here's what makes SEC mutual fund reporting uniquely reliable-and why it matters for your 401(k)

View Story

The Schwab U.S. Dividend Equity ETF: A Long-Term Income Generator

With a 3.3% yield and a focus on high-quality dividend stocks, the Schwab U.S. Dividend Equity ETF offers investors a way to build growing income streams over time-if they reinvest and stay patient through market cycles

View Story

How Much SpaceX Stock Is in Vanguard ETFs?

Vanguard ETFs are now holding SpaceX stock after its IPO, but exposure varies widely by fund and is still limited by float. Investors weighing SpaceX exposure should understand which ETFs include it and how much it represents in each portfolio

View Story

Vanguard Real Estate ETF vs FlexShares Global Quality Real Estate Index Fund: A Comparison

VNQ and GQRE both target real estate, but differ sharply on fees, yield, and global reach. Investors weighing cost, income, and diversification will find key trade-offs in expense ratios, dividend yields, and market exposure

View Story

Vanguard Financials ETF vs Fidelity MSCI Financials Index ETF: A Comparison

Vanguard Financials ETF and Fidelity MSCI Financials Index ETF both offer broad access to U.S. financial stocks, but differ in asset size, expense ratio, and top holdings-key factors for investors weighing sector exposure

View Story

State Street Health Care Select Sector SPDR ETF vs. First Trust NYSE Arca Biotechnology Index Fund: A Comparison

Healthcare ETFs XLV and FBT offer sharply different approaches-one broad and low-cost, the other biotech-focused and higher risk. See how their fees, returns, volatility, and holdings stack up before choosing where to invest

View Story

DOL Faces 40,000 Comments on New Retirement Plan Rules

The Department of Labor's proposed ERISA regulations have sparked over 40,000 public comments, revealing sharp divides among fiduciaries, plan sponsors, and industry groups over how retirement plans should handle private assets and litigation risk

View Story